Hayek Kallen Investment Management Novo Nordisk A S Transaction History

Hayek Kallen Investment Management

  • $272 Million
  • Q1 2025

A detailed history of Hayek Kallen Investment Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Hayek Kallen Investment Management holds 50,996 shares of NVO stock, worth $2.6 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares
50,996
Previous 55,220 7.65%
Holding current value
$2.6 Million
Previous $4.75 Million 25.45%
% of portfolio
1.3%
Previous 1.73%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$69.3 - $90.95 $292,723 - $384,172
-4,224 Reduced 7.65%
50,996 $3.54 Million
Q4 2024

Feb 14, 2025
SELL
$85.0 - $120.04 $113,900 - $160,853
-1,340 Reduced 2.37%
55,220 $4.75 Million
Q3 2024

Oct 15, 2024
SELL
$119.07 - $145.42 $160,744 - $196,316
-1,350 Reduced 2.33%
56,560 $6.74 Million
Q2 2024

Jul 18, 2024
SELL
$122.71 - $146.91 $88,964 - $106,509
-725 Reduced 1.24%
57,910 $8.27 Million
Q1 2024

May 03, 2024
SELL
$102.11 - $135.92 $190,230 - $253,218
-1,863 Reduced 3.08%
58,635 $7.53 Million
Q4 2023

Feb 08, 2024
SELL
$87.78 - $105.45 $418,096 - $502,258
-4,763 Reduced 7.3%
60,498 $6.26 Million
Q3 2023

Nov 07, 2023
BUY
$90.94 - $199.54 $2.9 Million - $6.37 Million
31,913 Added 95.7%
65,261 $5.94 Million
Q2 2023

Aug 11, 2023
BUY
$155.98 - $172.65 $37,435 - $41,436
240 Added 0.72%
33,348 $5.4 Million
Q1 2023

May 08, 2023
SELL
$132.34 - $159.14 $240,594 - $289,316
-1,818 Reduced 5.21%
33,108 $5.27 Million
Q4 2022

Feb 09, 2023
SELL
$102.55 - $135.33 $61,530 - $81,198
-600 Reduced 1.69%
34,926 $4.73 Million
Q3 2022

Oct 19, 2022
SELL
$95.28 - $116.93 $16,674 - $20,462
-175 Reduced 0.49%
35,526 $3.54 Million
Q2 2022

Aug 11, 2022
SELL
$103.24 - $121.81 $64,525 - $76,131
-625 Reduced 1.72%
35,701 $3.98 Million
Q1 2022

May 09, 2022
SELL
$93.1 - $112.54 $67,497 - $81,591
-725 Reduced 1.96%
36,326 $4.03 Million
Q4 2021

Feb 08, 2022
SELL
$95.88 - $117.08 $93,483 - $114,153
-975 Reduced 2.56%
37,051 $4.15 Million
Q3 2021

Oct 06, 2021
SELL
$84.42 - $106.62 $149,338 - $188,610
-1,769 Reduced 4.45%
38,026 $3.65 Million
Q2 2021

Aug 12, 2021
SELL
$67.66 - $84.76 $13,396 - $16,782
-198 Reduced 0.5%
39,795 $3.33 Million
Q3 2020

Nov 12, 2020
SELL
$63.69 - $70.22 $23,246 - $25,630
-365 Reduced 0.9%
39,993 $2.78 Million
Q2 2020

Sep 10, 2020
SELL
$58.54 - $67.94 $21,893 - $25,409
-374 Reduced 0.92%
40,358 $2.64 Million
Q1 2020

Apr 22, 2020
SELL
$49.46 - $64.78 $40,309 - $52,795
-815 Reduced 1.96%
40,732 $2.45 Million
Q4 2019

Feb 13, 2020
SELL
$49.86 - $58.26 $2,991 - $3,495
-60 Reduced 0.14%
41,547 $2.41 Million
Q3 2019

Nov 05, 2019
SELL
$47.54 - $53.43 $20,109 - $22,600
-423 Reduced 1.01%
41,607 $2.15 Million
Q2 2019

Jul 17, 2019
SELL
$46.79 - $52.47 $10,621 - $11,910
-227 Reduced 0.54%
42,030 $2.15 Million
Q1 2019

May 09, 2019
SELL
$46.36 - $52.63 $14,835 - $16,841
-320 Reduced 0.75%
42,257 $2.21 Million
Q4 2018

Jan 16, 2019
BUY
$41.54 - $47.25 $2,575 - $2,929
62 Added 0.15%
42,577 $1.96 Million
Q3 2018

Nov 09, 2018
SELL
$46.76 - $51.24 $38,904 - $42,631
-832 Reduced 1.92%
42,515 $2 Million
Q3 2018

Nov 09, 2018
BUY
$46.76 - $51.24 $48,957 - $53,648
1,047 Added 2.48%
43,347 $2.14 Million
Q2 2018

Aug 03, 2018
SELL
$44.29 - $50.42 $46,371 - $52,789
-1,047 Reduced 2.42%
42,300 $1.95 Million
Q1 2018

May 10, 2018
SELL
$48.49 - $58.14 $73,947 - $88,663
-1,525 Reduced 3.4%
43,347 $2.14 Million
Q4 2017

Feb 08, 2018
SELL
$47.53 - $53.73 $23,765 - $26,865
-500 Reduced 1.1%
44,872 $2.41 Million
Q3 2017

Oct 25, 2017
BUY
$41.15 - $49.22 $1.87 Million - $2.23 Million
45,372
45,372 $2.19 Million

Others Institutions Holding NVO

# of Institutions
1,742
Shares Held
338M
Call Options Held
10.9M
Put Options Held
15.9M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $115B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Hayek Kallen Investment Management Portfolio

Follow Hayek Kallen Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hayek Kallen Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hayek Kallen Investment Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email